DONACO INTERNATIONAL LIMITED (DNA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

DNA - DONACO INTERNATIONAL LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Consumer Services
Debt/EBITDA: 1.37
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.034

22 Apr
2024

0.000

OPEN

$0.03

0.000

HIGH

$0.03

0

LOW

$0.03

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 05/10 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-3.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx24.3 M
Book Value Per Share xxxxxxxxxxxxxxx9.8
Net Operating Cash Flow xxxxxxxxxxxxxxx11.3 M
Net Profit Margin xxxxxxxxxxxxxxx-151.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-26.93 %
Return on Invested Capital xxxxxxxxxxxxxxx-25.29 %
Return on Assets xxxxxxxxxxxxxxx-19.29 %
Return on Equity xxxxxxxxxxxxxxx-26.93 %
Return on Total Capital xxxxxxxxxxxxxxx-4.01 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx11.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx18 M
Long Term Debt xxxxxxxxxxxxxxx9 M
Total Debt xxxxxxxxxxxxxxx27 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx17 M
Price To Book Value xxxxxxxxxxxxxxx0.41

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.55 %
Cost of Goods Sold xxxxxxxxxxxxxxx16 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx15 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

DNA STOCK CHART